Literature DB >> 16521260

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Satoshi Gando1, Toshiaki Iba, Yutaka Eguchi, Yasuhiro Ohtomo, Kohji Okamoto, Kazuhide Koseki, Toshihiko Mayumi, Atsuo Murata, Toshiaki Ikeda, Hiroyasu Ishikura, Masashi Ueyama, Hiroshi Ogura, Shigeki Kushimoto, Daizoh Saitoh, Shigeatsu Endo, Shuji Shimazaki.   

Abstract

OBJECTIVES: To validate scoring algorithm criteria established by the Japanese Association for Acute Medicine (JAAM) for disseminated intravascular coagulation (DIC) and to evaluate its diagnostic property by comparing the two leading scoring systems for DIC, from the Japanese Ministry of Health and Welfare (JMHW) and International Society on Thrombosis and Haemostasis (ISTH).
DESIGN: Prospective, multicenter study during a 3-month period.
SETTING: General critical care center in a tertiary care hospital. PATIENTS: Two hundred seventy-three patients with platelet counts<150x109/L were enrolled. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: The JAAM, JMHW, and ISTH DIC scoring algorithms were prospectively applied within 12 hrs of patients meeting the inclusion criteria (day 0) to days 1-3, by global coagulation tests. The numbers of systemic inflammatory response syndrome (SIRS) criteria and Sequential Organ Failure Assessment (SOFA) scores were determined simultaneously. Mortality associated with any cause was also assessed 28 days after the enrollment. All global coagulation tests and SIRS criteria adopted in the JAAM criteria and their cutoff points were validated with use of SOFA scores and mortality rate. DIC diagnostic rate of the JAAM DIC scoring system was significantly higher than that of the other two criteria (p<.001). The JAAM DIC algorithm was the most sensitive for early diagnosis of DIC (p<.001). PATIENTS who fulfilled the JAAM DIC criteria included almost all those whose DIC was diagnosed by the JMHW and ISTH scoring systems. The JAAM DIC scores showed significant correlation with SOFA scores ([rho]=0.499; p<.001). SOFA score and mortality rate worsened in accordance with an increase in the JAAM DIC score. Fibrinogen criteria had little effect in predicting outcome for the DIC patients, and a total score of 4 points in the JAAM scoring system without fibrinogen was closely related to poor prognosis. According to the results, we revised the JAAM criteria by excluding fibrinogen and confirmed that the DIC diagnostic properties of original criteria remained unchanged in the revised JAAM criteria.
CONCLUSIONS: The JAAM scoring system has an acceptable property for the diagnosis of DIC. The scoring system identified most of the patients diagnosed by the JMHW and ISTH criteria. Revised JAAM DIC criteria preserved all properties of the original criteria for DIC diagnosis. The revised scoring system can be useful for selecting DIC patients for early treatment in a critical care setting.

Entities:  

Mesh:

Year:  2006        PMID: 16521260     DOI: 10.1097/01.ccm.0000202209.42491.38

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  167 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis.

Authors:  Leonora R Slatnick; Dianne Thornhill; Sara J Deakyne Davies; James B Ford; Halden F Scott; Marilyn J Manco-Johnson; Beth Boulden Warren
Journal:  J Pediatr       Date:  2020-06-14       Impact factor: 4.406

3.  A super-elderly case of abdominal aortic aneurysm associated with chronic disseminated intravascular coagulation.

Authors:  Kazunori Otsui; Mai Yamamoto; Humiaki Aoki; Toru Ozawa; Koji Domoto; Atsushi Suzuki; Sachiyo Iwata; Asumi Takei; Shinya Inamoto; Nobutaka Inoue
Journal:  J Cardiol Cases       Date:  2014-11-26

4.  Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan.

Authors:  Shinya Osone; Keitaro Fukushima; Michihiro Yano; Mariko Kakazu; Hirozumi Sano; Yoko Kato; Yuichi Shinkoda; Kunihiro Shinoda; Naoko Mori; Souichi Adachi
Journal:  Int J Hematol       Date:  2019-09-26       Impact factor: 2.490

5.  Disseminated intravascular coagulation score is associated with mortality for children with shock.

Authors:  Robinder G Khemani; Robert D Bart; Todd A Alonzo; George Hatzakis; Douglas Hallam; Christopher J L Newth
Journal:  Intensive Care Med       Date:  2008-09-18       Impact factor: 17.440

6.  The Japanese guidelines for the management of sepsis.

Authors:  Shigeto Oda; Mayuki Aibiki; Toshiaki Ikeda; Hitoshi Imaizumi; Shigeatsu Endo; Ryoichi Ochiai; Joji Kotani; Nobuaki Shime; Osamu Nishida; Takayuki Noguchi; Naoyuki Matsuda; Hiroyuki Hirasawa
Journal:  J Intensive Care       Date:  2014-10-28

Review 7.  The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.

Authors:  Karen M Hook; Charles S Abrams
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

Review 8.  Treatment for primary postpartum haemorrhage.

Authors:  Hatem A Mousa; Jennifer Blum; Ghada Abou El Senoun; Haleema Shakur; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2014-02-13

9.  Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study.

Authors:  Rakshit Panwar; Bala Venkatesh; Peter Kruger; Robert Bird; Devinder Gill; Leo Nunnink; Goce Dimeski
Journal:  J Hematol Oncol       Date:  2009-10-19       Impact factor: 17.388

Review 10.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.